pmid,title,journal,year,drug,disease
40905188,Effectiveness of molnupiravir for the treatment of COVID-19: a systematic literature review of real-world observational studies.,Current medical research and opinion,2025,Molnupiravir,Type 2 Diabetes
40736492,Top 20 Research Studies of 2024 for Primary Care Physicians.,American family physician,2025,Molnupiravir,Type 2 Diabetes
39109461,Comparing the effectiveness of molnupiravir and nirmatrelvir-ritonavir in non-hospitalized and hospitalized COVID-19 patients with type 2 diabetes: A target trial emulation study.,"Diabetes, obesity & metabolism",2024,Molnupiravir,Type 2 Diabetes
37204790,Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.,JAMA network open,2023,Molnupiravir,Type 2 Diabetes
36845041,Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol.,Heliyon,2023,Molnupiravir,Type 2 Diabetes
35743273,Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern.,International journal of molecular sciences,2022,Molnupiravir,Type 2 Diabetes
